Larimar Therapeutics, Inc. (LRMR)
Headquartered in Bala Cynwyd, Pennsylvania, Larimar Therapeutics, Inc. operates as a clinical-stage biotechnology firm. Its core mission involves crafting therapies for rare diseases, leveraging a distinctive cell-penetrating peptide technology platform. The company's foremost experimental therapy, CTI-1601, is presently undergoing Phase 1 clinical trials. This drug candidate is being developed to combat Friedreich's ataxia, a genetic illness that is rare, relentlessly progressive, and ultimately fatal.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Larimar Therapeutics, Inc.
NASDAQ:LRMRHealthcare · Biotechnology
+3.52%$2.35
AH Close$2.35+0.00%vs close
AH Close$2.35+0.00%vs close
Mkt Cap$244.12M
Float61.69M
O/S103.88M
Inst Own92.0%
SI24.9%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$165.67M
Total Assets$145.84M
Free Cash Flow-$113.29M
Debt & Equity
Debt 5%
Equity 95%
Total Debt$4.07M
Total Equity$78.08M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in LRMR's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$145.84M
Liabilities$67.76M
Accounts Receivable$747K
Accounts Payable$5.22M
Inventory$0
PP&E (Net)$2.69M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $155K | $78K | $261K | $188K | $212K | $70K | $0 | $12K | $11K | $4K |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | -$155K | -$78K | -$261K | -$188K | -$212K | -$70K | $0 | -$12K | -$11K | -$4K |
| Gross Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research and Development | $154.22M | $73.28M | $27.67M | $24.25M | $38.4M | $31.25M | $20.79M | $49.53M | $41.74M | $39.77M | $54.62M | $27.39M | $9.56M | $11.54M | $11.4M |
| Selling, General, and Administrative | $18.27M | $17.61M | $14.09M | $12.28M | $12.07M | $11.4M | $2.42M | $12.93M | $11.95M | $17.14M | $19.13M | $8.14M | $4.21M | $2.24M | $1.75M |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $82K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $172.5M | $90.89M | $41.76M | $36.53M | $50.47M | $42.65M | $23.21M | $62.46M | $53.69M | $56.91M | $73.74M | $35.53M | $13.77M | $13.78M | $13.15M |
| Operating Income (EBIT) | -$172.5M | -$90.89M | -$41.76M | -$36.53M | -$50.47M | -$42.8M | -$23.21M | -$62.72M | -$53.88M | -$57.12M | -$73.81M | -$35.53M | -$13.78M | -$13.79M | -$13.15M |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $971K | $347K | $806K | -$870K | $0 | $97K | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $996K | $894K | $438K | $28K | $0 | $0 | $0 |
| Other Income (Expense) | $6.82M | $10.29M | $4.81M | $1.17M | -$171K | $322K | $82K | -$246K | $947K | -$1.06M | -$473K | -$1.04M | -$247K | -$89K | -$3K |
| Income Before Tax (EBT) | -$165.67M | -$80.6M | -$36.95M | -$35.35M | -$50.64M | -$42.48M | -$23.13M | -$62.97M | -$52.93M | -$58.18M | -$74.29M | -$36.57M | -$14.03M | -$13.88M | -$13.16M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$1.6M | -$900K | -$300K | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$165.67M | -$80.6M | -$36.95M | -$35.35M | -$50.64M | -$42.33M | -$23.13M | -$61.37M | -$52.03M | -$57.88M | -$74.29M | -$36.57M | -$14.03M | -$13.88M | -$13.16M |
| Net Income Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Supplementary Data | |||||||||||||||
| EPS | -2.27 | -1.32 | -0.84 | -1.33 | -2.93 | -3.56 | -2.51 | -22.85 | -22.76 | -25.44 | -33.32 | -15.14 | -6.54 | -6.40 | -6.07 |
| Diluted EPS | -2.27 | -1.32 | -0.84 | -1.33 | -2.93 | -3.56 | -2.51 | -22.85 | -22.76 | -25.44 | -33.32 | -15.14 | -6.54 | -6.40 | -6.07 |
| Weighted Average OS | 72.95M | 61.26M | 43.90M | 25.76M | 17.16M | 11.88M | 9.21M | 2.69M | 2.29M | 2.27M | 2.23M | 2.42M | 2.18M | 2.18M | 2.18M |
| EBITDA | -$165.32M | -$80.29M | -$36.64M | -$35.04M | -$50.31M | -$42.65M | -$23.14M | -$60.81M | -$52.58M | -$57.44M | -$73.41M | -$35.59M | -$14.02M | -$13.77M | -$13.15M |
| EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash and Cash Equivalents | $85.41M | $33.22M | $26.75M | $26.82M | $70.1M | $68.15M | $1.01M | $49.33M | $40.78M | $32.35M | $35.59M | $58.1M | $35.52M | $9.94M |
| Short-Term Investments | $51.44M | $150.24M | $60.04M | $91.6M | $0 | $24.49M | $0 | $68.73M | $61.27M | $96.84M | $149.48M | $57.36M | $0 | $0 |
| Cash and Short-Term Investments | $136.85M | $183.45M | $86.79M | $118.43M | $70.1M | $92.64M | $1.01M | $118.07M | $102.05M | $129.19M | $185.08M | $115.46M | $35.52M | $9.94M |
| Accounts Receivable | $747K | $1.05M | $332K | $0 | $208K | $32K | $158K | $1.54M | $946K | $347K | $1.32M | $0 | $1.62M | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $253K | $517K | $377K | $238K | $279K | $251K | $448K | $1.73M | $1.93M | $1.36M | $1.71M | $1.74M | $224K | $389K |
| Total Current Assets | $142.02M | $195.3M | $90.17M | $120.74M | $72.2M | $97.95M | $4.75M | $121.33M | $104.92M | $130.9M | $188.11M | $117.2M | $37.36M | $10.32M |
| Long-Term Assets | ||||||||||||||
| Property, Plant & Equipment Net | $2.69M | $3.72M | $3.76M | $3.69M | $4.46M | $4.98M | $361K | $375K | $528K | $661K | $902K | $79K | $37K | $32K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $1.34M | $0 | $1.34M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $630K |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $1.13M | $1.2M | $659K | $1.98M | $669K | $1.76M | $90K | $57K | $57K | $61K | $94K | $242K | $743K | $0 |
| Total Long-Term Assets | $3.82M | $4.92M | $5.76M | $5.67M | $6.46M | $6.73M | $451K | $432K | $585K | $722K | $996K | $321K | $780K | $662K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $145.84M | $200.22M | $95.94M | $126.41M | $78.67M | $104.69M | $5.2M | $121.76M | $105.51M | $131.62M | $189.11M | $117.52M | $38.14M | $10.99M |
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payable | $5.22M | $2.42M | $1.28M | $1.69M | $1.66M | $2.63M | $3.54M | $909K | $0 | $0 | $0 | $0 | $0 | $0 |
| Short-Term Debt | $1.1M | $0 | $0 | $0 | $0 | $0 | $0 | $5.46M | $0 | $3.59M | $2.94M | $1.38M | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$5.46M | $0 | -$2.57M | -$2.94M | $0 | $0 | $0 |
| Other Current Liabilities | $54.69M | $0 | $0 | $0 | $0 | $0 | $0 | $4.65M | $4.27M | $6.3M | $9.05M | $3.17M | $2.87M | $2.86M |
| Total Current Liabilities | $64.8M | $24.36M | $9.51M | $10.71M | $8.85M | $8.99M | $5.89M | $13.31M | $7.29M | $9.89M | $16.54M | $6.9M | $2.92M | $2.93M |
| Long-Term Liabilities | ||||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $15.19M | $20M | $0 | $3.45M | $6.18M | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $2.96M | $4.06M | $4.71M | $4.8M | $5.41M | $6M | $0 | $15.19M | $20M | $0 | $3.45M | $6.18M | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $67.76M | $28.41M | $14.21M | $15.5M | $14.25M | $14.99M | $5.89M | $28.49M | $27.29M | $9.89M | $20M | $13.08M | $2.92M | $2.93M |
| Stockholders' Equity | ||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $117.52M | $103.8M | $62.78M |
| Common Stock | $83K | $64K | $43K | $43K | $18K | $15K | $6K | $37K | $27K | $27K | $27K | $23K | $1K | $1K |
| Retained Earnings | -$434.83M | -$269.16M | -$188.55M | -$151.6M | -$116.25M | -$65.61M | -$23.13M | -$350.94M | -$289.58M | -$237.55M | -$179.67M | -$105.39M | -$68.91M | -$54.88M |
| Comprehensive Income & Other | $54K | $148K | $81K | -$31K | -$0 | $1K | $0 | -$33K | -$58K | -$80K | -$207K | -$35K | $0 | $0 |
| Other Stockholders' Equity | $512.83M | $440.91M | $270.23M | $262.46M | $180.65M | $155.29M | $22.43M | $444.18M | $367.77M | $359.25M | $348.75M | $209.8M | $104.13M | $62.94M |
| Total Equity | $78.08M | $171.81M | $81.72M | $110.9M | $64.41M | $89.69M | -$694K | $93.27M | $78.22M | $121.73M | $169.11M | $104.44M | $35.22M | $8.06M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $145.84M | $200.22M | $95.94M | $126.41M | $78.67M | $104.69M | $5.2M | $121.76M | $105.51M | $131.62M | $189.11M | $117.52M | $38.14M | $10.99M |
| Supplementary Data | ||||||||||||||
| Total Debt | $4.07M | $5.12M | $5.55M | $5.41M | $6M | $6.52M | $97K | $20.64M | $20M | $3.59M | $6.39M | $7.56M | $0 | $0 |
| Net Debt | -$81.34M | -$28.1M | -$21.2M | -$21.42M | -$64.09M | -$61.63M | -$912K | -$28.69M | -$20.78M | -$28.76M | -$29.21M | -$50.55M | -$35.52M | -$9.94M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
| Operating Activities | |||||||||||||||
| Net Income | -$165.67M | -$80.6M | -$36.95M | -$35.35M | -$50.64M | -$42.48M | -$23.13M | -$61.37M | -$52.03M | -$57.88M | -$74.29M | -$36.48M | -$14.03M | -$13.88M | -$13.16M |
| Depreciation & Amortization | $350K | $318K | $311K | $318K | $326K | $155K | $78K | $261K | $188K | $212K | $70K | $16K | $12K | $11K | $4K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$9.63M | $0 | $0 | -$8.58M | -$815K | $0 | $0 | $0 |
| Stock-Based Compensation | $7M | $8.8M | $7.62M | $6.62M | $5.47M | $2.16M | $129K | $173K | $0 | $0 | $8.58M | $1.55M | $0 | $0 | $0 |
| Changes in Working Capital: | |||||||||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $1.29M | -$666K | -$553K | $970K | -$1.01M | $0 | -$1.24M | -$630K | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $2.79M | $1.14M | -$403K | $26K | -$974K | -$3.29M | $2.63M | $432K | -$448K | $4.92M | $4.91M | $815K | $0 | $0 | $0 |
| Other Working Capital | $44.3M | $5.03M | -$2.11M | $1.64M | $3.72M | $1.25M | -$3.69M | $827K | $454K | -$6.47M | $7.74M | -$815K | -$397K | $692K | $801K |
| Total Working Capital Change | $47.1M | $6.17M | -$2.51M | $1.67M | $2.75M | -$2.04M | $226K | $593K | -$99K | -$5.5M | $6.73M | $815K | -$1.63M | $62K | $801K |
| Other Non-Cash Items | -$1.98M | -$5.45M | -$1.93M | -$820K | -$15K | $10K | $0 | $9.78M | $9.08M | $10.64M | $9.09M | $6.67M | $645K | $218K | $78K |
| Net Cash from Operating | -$113.2M | -$70.76M | -$33.46M | -$27.57M | -$42.1M | -$42.2M | -$22.7M | -$51.49M | -$43.78M | -$51.98M | -$59.55M | -$28.24M | -$15M | -$13.59M | -$12.27M |
| Investing Activities | |||||||||||||||
| Capital Expenditures | -$91K | -$515K | -$164K | -$100K | -$333K | -$62K | -$83K | -$108K | -$55K | -$660K | -$595K | -$58K | -$17K | -$2K | -$35K |
| Acquisitions | $0 | $0 | $0 | $91K | -$25K | -$1.3M | $0 | $6.76M | $0 | $0 | $91.5M | $0 | $0 | $0 | $2K |
| Purchases of Investments | -$83.6M | -$227.87M | -$101.23M | -$133.61M | -$8.25M | -$24.49M | $0 | -$117.15M | -$114.51M | -$136.53M | -$287.49M | -$57.2M | $0 | $0 | $0 |
| Sales of Investments | $184M | $143M | $134.75M | $42.75M | $32.75M | $1M | $0 | $110.39M | $150.21M | $188.6M | $195.99M | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | -$91K | $25K | $41.93M | $0 | -$6.76M | $35.7M | $35K | -$19K | -$57K | $0 | $0 | -$12K |
| Net Cash from Investing | $100.31M | -$85.39M | $33.35M | -$90.96M | $24.17M | $17.09M | -$83K | -$6.87M | $35.65M | $51.45M | -$92.12M | -$57.31M | -$17K | -$2K | -$45K |
| Financing Activities | |||||||||||||||
| Debt Repaid | - | - | - | - | - | - | - | - | -$16.37M | $2.94M | $1.38M | -$7.34M | - | -$5.99M | - |
| Common Stock Issuance | $65.09M | $161.81M | $30K | $75.26M | $19.89M | $75.59M | $19.39M | $66.91M | $195K | $220K | $130.54M | $3.57M | $40.6M | $16.06M | $10.07M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $67.22M | $195K | $220K | $131.02M | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $77K | $0 | $0 | $0 | $18M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $13K | $0 |
| Net Cash from Financing | $65.09M | $161.88M | $30K | $75.26M | $19.89M | $93.59M | $19.39M | $66.91M | $16.56M | -$2.71M | $129.16M | $108.14M | $40.6M | $22.06M | $10.07M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | -$44.94M | $0 | $0 | $0 | -$58.1M | $0 | $0 | $0 | $0 |
| Net Change in Cash | $52.19M | $5.74M | -$76K | -$43.27M | $1.95M | $68.48M | -$48.32M | $8.55M | $8.43M | -$3.24M | -$22.51M | $22.59M | $0 | $0 | $0 |
| Supplementary Data | |||||||||||||||
| Operating Cash Flow | -$113.2M | -$70.76M | -$33.46M | -$27.57M | -$42.1M | -$42.2M | -$22.7M | -$51.49M | -$43.78M | -$51.98M | -$59.55M | -$28.24M | -$15M | -$13.59M | -$12.27M |
| Capital Expenditure | -$91K | -$515K | -$164K | -$100K | -$333K | -$62K | -$83K | -$108K | -$55K | -$660K | -$595K | -$58K | -$17K | -$2K | -$35K |
| Free Cash Flow | -$113.29M | -$71.28M | -$33.62M | -$27.67M | -$42.44M | -$42.26M | -$22.78M | -$51.59M | -$43.84M | -$52.63M | -$60.15M | -$28.3M | -$15.02M | -$13.59M | -$12.31M |
| Cash at Beginning | $33.82M | $28.09M | $26.82M | $71.44M | $69.49M | $1.01M | $49.33M | $40.78M | $32.35M | $35.59M | $58.1M | $35.52M | $9.94M | $0 | $0 |
| Cash at End | $86.02M | $33.82M | $26.75M | $28.16M | $71.44M | $69.49M | $1.01M | $49.33M | $40.78M | $32.35M | $35.59M | $58.1M | $35.52M | $9.94M | $0 |